Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thoracic paravertebral block with different liposomal bupivacaine concentrations in thoracoscopic lung surgery
ChiCTR2600133484Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Oct 2026
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine and bupivacaine in postoperative pain (4 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Quality of Recovery-15 score at 24 hours after surgery. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
liposomal bupivacainebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600133484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133484.